MTX2

MTX2 (Metaxin-2) is an outer mitochondrial membrane protein essential for mitochondrial protein import, cristae architecture, oxidative phosphorylation, and cellular homeostasis across metazoans. MTX2 forms a complex with MTX1 through its N-terminal domain and maintains the Sam50-CHCHD3-Mitofilin (MIB) complex required for normal cristae morphology and respiratory complex I/III function; its loss causes mitochondrial fragmentation, increased ROS, impaired oxidative phosphorylation, increased mitophagy, and secondary nuclear morphology defects (PMID:32917887, PMID:38250156). The TOM37 domain of MTX2 directly binds PKM2 to promote its tetramerization and enhance glycolytic flux, while MTX2 protein stability is regulated by AREL1-mediated K48-linked ubiquitination and USP10-mediated deubiquitination at K93, with USP10 loss triggering MTX2 degradation, mitochondrial DNA release, and cGAS-STING pathway activation (PMID:40585998, PMID:34584540, PMID:41705350). Biallelic loss-of-function mutations in MTX2 cause a premature aging syndrome with mitochondrial dysfunction and nuclear envelope abnormalities in humans (PMID:32917887).

1. 2020 High

   Establishing MTX2 as essential for mitochondrial and nuclear integrity: patient fibroblasts and C. elegans depletion revealed that MTX2 loss destabilizes MTX1, fragments the mitochondrial network, impairs oxidative phosphorylation, induces senescence and mitophagy, and secondarily disrupts nuclear morphology—linking outer mitochondrial membrane composition to nuclear envelope homeostasis.

   Evidence Patient fibroblast analysis with MTX2 loss-of-function, C. elegans mtx-2 depletion, oxidative phosphorylation assays, apoptosis resistance and mitophagy quantification

   PMID:32917887

   Open questions at the time

   • Mechanism by which mitochondrial dysfunction propagates to nuclear envelope defects is undefined
   • Whether MTX2 directly participates in protein import or acts indirectly through MTX1 stabilization was not resolved
   • No specific mitochondrial import substrates identified
2. 2021 Medium

   Identifying post-translational regulation of MTX2: AREL1 was shown to ubiquitinate MTX2 at its C-terminal domain for proteasomal degradation, and this degradation suppresses TNF-induced necroptosis, placing MTX2 turnover upstream of necroptotic signaling.

   Evidence Reciprocal co-immunoprecipitation, domain mapping, AREL1 catalytic mutant (C790A), AREL1 knockdown and overexpression

   PMID:34584540

   Open questions at the time

   • Specific ubiquitination sites on MTX2 targeted by AREL1 were not mapped
   • Mechanism connecting MTX2/MTX1 to necroptosis execution machinery is unknown
   • Single-lab finding not independently replicated
3. 2024 High

   Defining the cristae-organizing role of MTX2: podocyte-specific Mtx2 knockout revealed that MTX2 maintains the Sam50-CHCHD3-Mitofilin (MIB) complex, and its loss causes cristae disorganization, respiratory complex I/III deficiency, increased ROS, and podocyte functional impairment leading to glomerular disease in vivo.

   Evidence Conditional podocyte-specific Mtx2 KO mice, in vitro rescue by MTX2 overexpression, mitochondrial complex activity assays, ROS measurement, western blotting for MIB components

   PMID:38250156

   Open questions at the time

   • Whether MTX2 directly contacts Sam50 or acts through MTX1 to stabilize the MIB complex is unresolved
   • The structural basis of MTX2-MIB interaction is unknown
4. 2024 Medium

   Connecting MTX2 to organismal aging pathways: C. elegans mtx-2 deficiency caused cuticle abnormalities, reduced mitochondrial respiration, and transcriptomic perturbations in aging, TOR, and WNT signaling, extending the functional scope of MTX2 beyond cell-autonomous mitochondrial defects.

   Evidence Atomic force microscopy, oxygen consumption rate analysis, transcriptomics in mtx-2-deficient C. elegans

   PMID:39462037

   Open questions at the time

   • Whether TOR and WNT pathway changes are direct or secondary to mitochondrial dysfunction is unknown
   • Causal relationship between cuticle defects and mitochondrial impairment not established
5. 2025 High

   Revealing a direct metabolic effector function: the TOM37 domain of MTX2 was found to directly bind PKM2 and promote its tetramerization, enhancing glycolytic flux; cardiomyocyte-specific Mtx2 deletion impaired both glycolysis and oxidative phosphorylation after ischemia/reperfusion, and pharmacological PKM2 tetramerization rescued the injury phenotype.

   Evidence Cardiomyocyte-specific Mtx2 KO mice, mass spectrometry, co-immunoprecipitation, Seahorse metabolic analysis, TEPP-46 pharmacological rescue

   PMID:40585998

   Open questions at the time

   • Whether PKM2 binding is constitutive or regulated by stress/metabolic state is unclear
   • Other TOM37 domain interaction partners have not been systematically catalogued
6. 2025 Medium

   Establishing a developmental requirement via the C-terminal GST-like domain: Xenopus mtx2 knockdown caused craniofacial defects through impaired neural crest cell proliferation, and domain-deletion rescue showed the C-terminal GST-like domain is essential while the N-terminal GST-like domain is dispensable for this function.

   Evidence Morpholino knockdown in Xenopus, domain-deletion rescue constructs, marker gene expression, proliferation and apoptosis assays

   PMID:40967033

   Open questions at the time

   • The molecular activity of the C-terminal GST-like domain (enzymatic vs. structural) is not defined
   • Whether craniofacial defects stem from mitochondrial dysfunction or a separate MTX2 function is unresolved
7. 2026 High

   Pinpointing a site-specific deubiquitination mechanism: USP10 was identified as the deubiquitinase that removes K48-linked ubiquitin from MTX2 at K93, stabilizing MTX2; USP10 loss causes MTX2 degradation, mitochondrial DNA release, and cGAS-STING activation, with the K93R mutation fully rescuing the cardiac injury phenotype.

   Evidence Immunoprecipitation mass spectrometry, ubiquitination assays, K93R mutagenesis, USP10 KO mice, neonatal rat cardiomyocyte culture

   PMID:41705350

   Open questions at the time

   • Whether K93 is the sole regulatory ubiquitination site or one of several is not resolved
   • The E3 ligase responsible for K93 ubiquitination (whether AREL1 or another) is not identified in this study
   • Mechanism linking MTX2 degradation to mitochondrial DNA release remains undefined

• Key unresolved questions include the structural basis of MTX2 integration into the outer mitochondrial membrane, the identity of specific protein import substrates that depend on MTX2, whether the AREL1-targeted and USP10-targeted ubiquitination events converge on the same site, and the mechanism by which mitochondrial dysfunction secondary to MTX2 loss causes nuclear envelope defects.
• No high-resolution structure of MTX2 or its complexes exists
• Specific mitochondrial import substrates dependent on MTX2 have not been identified
• The signaling pathway from mitochondrial dysfunction to nuclear morphology changes is unknown